Skip to main content

Table 3 Details of conversion surgery classified by procedure

From: Normalization of tumor markers and a clear resection margin affect progression-free survival of patients with unresectable pancreatic cancer who have undergone conversion surgery

 

PD

n = 31

DP

n = 20

DP-CAR

n = 11

TP

n = 1

Type of procedure

 LAPCa

25 (81)

13 (65)

10 (91)

1 (100)

 MPC

6 (19)

7 (35)

1 (9)

0 (0)

 Duration (min)

360 (234–593)

253 (133–463)

270 (219–420)

748

 Estimated blood loss (mL)

200 (50–1300)

200 (100–1300)

200 (100–1000)

300

Margin (microscopic)

 R0

25 (81)

17 (85)

8 (73)

1 (100)

 R1

4 (13)

2 (10)

2 (18)

0 (0)

 R2

2 (6)

1 (5)

1 (9)

0 (0)

Postoperative duration of hospital stay (days)

14 (6–53)

13(5–30)

19 (10–33)

15

Complications

 Pleural effusion

13 (42)

9 (45)

6 (55)

0(0)

 Ascites

13 (42)

8 (40)

2 (18)

0(0)

 Chylus fistula

8 (26)

2 (10)

4 (36)

0(0)

 Pancreatic fistula

3 (10)

5 (25)

5 (45)

0(0)

 Infection

3 (10)

2 (10)

4 (36)

1 (100)

Clavien–Dindo grade

 0

7 (23)

4 (20)

0 (0)

0 (0)

 I

16 (52)

6 (30)

3 (27)

0 (0)

 II

4 (13)

4 (20)

4 (36)

0 (0)

 III

4 (13)

6 (30)

4 (36)

0 (0)

 IV

0 (0)

0 (0)

0 (0)

0 (0)

 V

0 (0)

0 (0)

0 (0)

1 (100)

 30-day unplanned readmission to hospital

3 (10)

5 (25)

1 (0)

0 (0)

 Postoperative death (within 90 days)

0 (0)

0 (0)

0 (0)

1 (100)

 Unplanned reoperation

2 (6)

2 (10)

0 (0)

1 (100)

  1. aFour patients continued to have unresectable pancreatic cancer intraoperatively and were excluded
  2. PD pancreatoduodenectomy; DP distal pancreatectomy; TP total pancreatectomy; DP-CAR distal pancreatectomy with celiac axis resection